Vimarsana
Biggest News Aggregation in the World

Page 7 - Nasdaq Caba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Caba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Caba Today - Breaking & Trending Today

1,895,285 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by VR Adviser LLC - Vimarsana News

1,895,285 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by VR Adviser LLC

VR Adviser LLC purchased a new stake in shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Rating) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,895,285 shares of the company’s stock, valued at approximately $17,531,000. Cabaletta Bio comprises 2.8% of VR Adviser LLC’s portfolio, […]

Source: wkrb13.com
Cabaletta Bio (NASDAQ:CABA) Stock Price Down 1.5% - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 1.5%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Rating)’s stock price fell 1.5% during trading on Friday . The stock traded as low as $12.07 and last traded at $12.15. 201,284 shares were traded during trading, a decline of 57% from the average session volume of 467,154 shares. The stock had previously closed at $12.34. Analysts Set […]

Critical Contrast: Cabaletta Bio (NASDAQ:CABA) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Vimarsana News

Critical Contrast: Cabaletta Bio (NASDAQ:CABA) and Sorrento Therapeutics (OTCMKTS:SRNEQ)

Cabaletta Bio (NASDAQ:CABA – Get Rating) and Sorrento Therapeutics (OTCMKTS:SRNEQ – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership. Profitability This table compares Cabaletta Bio and Sorrento Therapeutics’ […]

Insider Selling: Cabaletta Bio, Inc. (NASDAQ:CABA) Insider Sells $259,820.00 in Stock - Vimarsana News

Insider Selling: Cabaletta Bio, Inc. (NASDAQ:CABA) Insider Sells $259,820.00 in Stock

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Rating) insider Gwendolyn Binder sold 22,000 shares of Cabaletta Bio stock in a transaction on Friday, May 19th. The stock was sold at an average price of $11.81, for a total transaction of $259,820.00. Following the completion of the transaction, the insider now directly owns 20,000 shares in the […]

Cabaletta Bio Announces Pricing of Public Offering of - Vimarsana News

Cabaletta Bio Announces Pricing of Public Offering of

PHILADELPHIA, May 17, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company...